Plea filed in SC seeking medical panel to look into Covishield risk factors
This development follows AstraZeneca admitting that its COVID-19 vaccine could cause blood clot-related side effects in ‘very rare’ cases.
1 May, 2024•2 min
0
1 May, 2024•2 min
0
Getting your Trinity Audio player ready...
More in Chaos
Chaos
India-US trade pact demonstrates how sovereignty is eroded in practice
The framework reads less like an agreement between partners and more like a probation order written by the stronger side.
You may also like
Business
Subsidies, soft demand and an open door to Europe: Sula’s perfect storm
In one of its worst years yet, India’s largest winemaker is facing headwinds on all fronts and has little by way of a plan.
Business
Business schools find themselves at a crossroads as the consulting spell breaks
While consulting remains the most sought-after career choice at top B-schools, the sector itself is experiencing its worst downturn in recent history.
Markets
Why Nifty 50’s profit is the lowest since COVID-19 pandemic
The earnings of India’s oil refiners and other Nifty 50 companies have taken a hit. But IPO premiums suggest that investors seem unfazed.
